This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Hemolysis in Blood Samples in the ER

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Olivier T. Rutschmann, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01815931
First received: March 19, 2013
Last updated: November 8, 2013
Last verified: November 2013
  Purpose
In this study, we aim to identify risk factors for hemolysis in blood samples drawn in the ED.

Condition
Hemolysis Emergency Service, Hospital Emergencies Blood Specimen Collection

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Olivier T. Rutschmann, University Hospital, Geneva:

Primary Outcome Measures:
  • Hemolysis rate [ Time Frame: 1 day ]

Enrollment: 2800
Study Start Date: June 2013
Study Completion Date: October 2013
Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
ED patients

  Eligibility

Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All adult (> 16 y) patients admitted in the emergency departement during the study period
Criteria

Inclusion Criteria:

  • > 16 years

Exclusion Criteria:

  • In vivo hemolysis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01815931

Locations
Switzerland
University Hospital, Geneva
Geneva, GE, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
  More Information

Responsible Party: Olivier T. Rutschmann, MD, MPH, University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT01815931     History of Changes
Other Study ID Numbers: SU-032013
Study First Received: March 19, 2013
Last Updated: November 8, 2013

Additional relevant MeSH terms:
Emergencies
Hemolysis
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on August 18, 2017